Homepage
PR Newswire
21-09-2023, 04:19 PM
(This post was last modified: 21-09-2023, 04:22 PM by dreamybear.)
Healthcare group with CAGR of 15.09% in each of the last 22 years.
----------------
https://disclosure.bursamalaysia.com/Fil...TTACHMENTS
"...2022 marks the 60th anniversary of the founding of the Group in 1962. From a retail pharmacy in Melaka, AHB has grown to a public company with a market capitalization of RM 1.68 billion1 with operations and commercial presence in 20 territories today. An initial investment in 1,000 shares at the time of AHB’s Initial Public Offering (‘IPO’) in year 2000 would be approximately 9,375 shares if held till today, after 4 bonus issues2 . At RM 1.50 per share at IPO, the value of that investment would be RM 33,000 today, based on the closing share price of RM 3.52 on 31st December 2022. This is a compound annual growth rate in value of 15.09% in each of the last 22 years and made possible through the support of every stakeholder, foremost our people, our customers, and our shareholders..."
https://apexhealthcare.com.my/dr-kee-kirk-chin/
Dr Kee Kirk Chin, 61, male, a Singaporean, was appointed to the Board on 15th February 2000, as the Managing Director of the Company on 3rd March 2000 and became Chairman and Chief Executive Officer on 19th May 2010. He obtained a Bachelor in Arts with Honours in 1985, a Bachelor of Medicine & Bachelor of Surgery in 1987 and a Master of Arts in 1989 from University of Cambridge, UK and a Master of Business Administration (MBA) with distinction in 1993 from University of Hull, UK.
----------------
https://disclosure.bursamalaysia.com/Fil...TTACHMENTS
"...2022 marks the 60th anniversary of the founding of the Group in 1962. From a retail pharmacy in Melaka, AHB has grown to a public company with a market capitalization of RM 1.68 billion1 with operations and commercial presence in 20 territories today. An initial investment in 1,000 shares at the time of AHB’s Initial Public Offering (‘IPO’) in year 2000 would be approximately 9,375 shares if held till today, after 4 bonus issues2 . At RM 1.50 per share at IPO, the value of that investment would be RM 33,000 today, based on the closing share price of RM 3.52 on 31st December 2022. This is a compound annual growth rate in value of 15.09% in each of the last 22 years and made possible through the support of every stakeholder, foremost our people, our customers, and our shareholders..."
https://apexhealthcare.com.my/dr-kee-kirk-chin/
Dr Kee Kirk Chin, 61, male, a Singaporean, was appointed to the Board on 15th February 2000, as the Managing Director of the Company on 3rd March 2000 and became Chairman and Chief Executive Officer on 19th May 2010. He obtained a Bachelor in Arts with Honours in 1985, a Bachelor of Medicine & Bachelor of Surgery in 1987 and a Master of Arts in 1989 from University of Cambridge, UK and a Master of Business Administration (MBA) with distinction in 1993 from University of Hull, UK.